Latest Safety News

Actinogen Medical has fast-tracked enrolment in its pivotal Alzheimer’s trial, secured a clear FDA regulatory path, and strengthened its financial position with funding extending its runway to mid-2026.

Karoon Energy reported a 12% production dip in Q3 2025 due to operational challenges but saw a 3% revenue increase driven by higher oil prices and secured a new deepwater block in Brazil.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Amaero Ltd reports a remarkable 445% increase in quarterly revenue driven by powder sales and manufacturing scale-up, alongside securing a US$22.8 million loan and exclusive supply agreements with key defense and aerospace players.

GR Engineering Services Limited reported a robust FY25 with revenue climbing to $479 million and EBITDA surging to $57.2 million, supported by successful project completions and an expanded contract pipeline. The company declared a higher fully franked dividend and maintains a strong cash position as it looks ahead to FY26.

MAAS Group Holdings reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by strong construction materials growth and strategic acquisitions. The company projects FY26 EBITDA between $240 million and $270 million, underpinned by renewable energy projects and a robust capital recycling program.

Aeris Resources reported steady Q1 FY26 production with 10.3kt copper equivalent at AISC of A$4.64/lb, alongside significant growth capital investment and promising exploration results.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Volt Resources has reached a key technical milestone by consistently producing ultra-high purity graphite using a proprietary, hydrofluoric acid-free process, paving the way for U.S.-based battery-grade graphite production.

Island Pharmaceuticals secures FDA confirmation that regulatory feedback on Galidesivir’s approval pathway will arrive on schedule, underscoring the drug’s strategic importance amid US government disruptions.

Renascor Resources reports steady progress on its Purified Spherical Graphite demonstration plant in Adelaide, backed by a $5 million government grant, aiming to challenge China’s dominance in battery materials.

Codan Limited reported a strong FY25 with significant revenue and profit growth, bolstered by a key U.S. acquisition and a robust outlook for FY26 driven by defense spending and gold market strength.